Health Affairs Article IDR ‘Cost’ Claim Inflated Due to Reliance on Flawed QPA Benchmark
Medical societies dispute Health Affairs analysis, arguing inaccurate insurer payment benchmarks skew No Surprises Act cost estimates.
Read moreHealth Affairs Article IDR ‘Cost’ Claim Inflated Due to Reliance on Flawed QPA Benchmark
Medical societies dispute Health Affairs analysis, arguing inaccurate insurer payment benchmarks skew No Surprises Act cost estimates.
Read moreSite-Neutral Payment in HOPPS Comments
ACR comments on CMS' 2027 HOPPS proposal, urging changes to site-neutral imaging payments and other radiology policies.
Read moreACR Advocates for Imaging Programs at NIH
Advocacy efforts highlight NIBIB funding and the PRIMED-AI initiative to advance medical imaging and AI-powered healthcare.
Read moreThis page was updated Nov. 11 with a revision to the MedPAC section.
ACR® will update this page with any developments that impact radiologists, practices and patients. ACR members, continue to read the ACR Advocacy in Action e-newsletter delivered to in your inbox Saturday mornings.
The following agencies have publicly posted shutdown contingency plans, which are summarized below. Each heading is a direct link to that respective plan.
Centers for Medicare & Medicaid Services (CMS):
Food and Drug Administration (FDA):
National Institutes of Health (NIH):
Advanced Research Projects Agency for Health (ARPA-H):
Centers for Disease Control and Prevention (CDC):
Department of Veterans Affairs (VA):
Nuclear Regulatory Commission (NRC):
We will continue to monitor developments and share updates as available.